ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 365 filers reported holding ASTRAZENECA PLC in Q2 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,585,909 | +49.0% | 52,952 | -31.5% | 0.61% | -6.1% |
Q1 2017 | $2,407,000 | +66.6% | 77,282 | +46.1% | 0.65% | +45.9% |
Q4 2016 | $1,445,000 | -6.4% | 52,888 | +12.7% | 0.45% | -29.2% |
Q3 2016 | $1,543,000 | +7.9% | 46,947 | -0.9% | 0.63% | +12.9% |
Q2 2016 | $1,430,000 | +78.1% | 47,353 | +66.0% | 0.56% | +270.2% |
Q1 2016 | $803,000 | -72.3% | 28,518 | -66.6% | 0.15% | -69.6% |
Q4 2015 | $2,898,000 | -28.1% | 85,375 | -32.6% | 0.50% | -39.6% |
Q3 2015 | $4,033,000 | -7.1% | 126,738 | +86.1% | 0.82% | +3.3% |
Q2 2015 | $4,340,000 | -6.8% | 68,114 | +0.1% | 0.80% | -6.7% |
Q1 2015 | $4,658,000 | -4.1% | 68,071 | -1.4% | 0.85% | -7.7% |
Q4 2014 | $4,859,000 | -6.8% | 69,036 | -5.4% | 0.92% | -8.9% |
Q3 2014 | $5,216,000 | -4.3% | 73,014 | -0.5% | 1.01% | +1.2% |
Q2 2014 | $5,451,000 | +15.0% | 73,355 | +0.4% | 1.00% | +20.9% |
Q1 2014 | $4,741,000 | +11.1% | 73,067 | +1.6% | 0.83% | -11.2% |
Q4 2013 | $4,268,000 | – | 71,885 | – | 0.93% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |